You just read:

World Lung Conference Features Data Demonstrating Clinical Utility and Cost Effectiveness of Trovagene's Liquid Biopsy Tests for Mutation Detection and Monitoring in NSCLC Patients

News provided by

Trovagene, Inc.

28 Nov, 2016, 08:00 ET